Oncimmune, a precision medicine company, has fallen into administration.
It follows attempts by the business to sell its German trading subsidiary and a failure to...
Mallinckrodt and Endo have entered into a definitive agreement to combine in a $6.7 billion deal, after the companies emerged from bankruptcy in connection...